MedTrace Logo

Thyroid Lobectomy With or Without Levothyroxine Treatment Postoperatively

NCT00941551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2009-07-17

No results posted yet for this study

Summary

The aim of this study was to compare the prevalence of recurrent nodular goiter in the contralateral thyroid lobe among patients after unilateral thyroid lobectomy for unilateral multinodular goiter receiving versus not receiving prophylactic levothyroxine treatment postoperatively in a five-year follow-up of a randomized study

Conditions

  • Recurrent Goiter

Interventions

DRUG

levothyroxine

levothyroxine 75-125 ug/day

DRUG

no levothyroxine

observation only without prophylactic levothyroxine

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Marcin Barczynski, MD, PhD · Jagiellonian University College of Medicine

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2003-12-31
Completion
2008-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00941551 on ClinicalTrials.gov